Policy | January 13, 2024
Health Minister Mandaviya inaugurates NIPER in Guwahati
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
The company has received five final approvals
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Sirius JV will be owned 51% by Sirius and 49% by Adani
Subscribe To Our Newsletter & Stay Updated
